Review



sub confluent huvec  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    ATCC sub confluent huvec
    Sub Confluent Huvec, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1606 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/confluent+huvec/HUV-EC-C/us11701366-312-0-7
    Average 96 stars, based on 1606 article reviews
    sub confluent huvec - by Bioz Stars, 2026-09
    96/100 stars

    Images

    Related Articles

    Cell Culture:

    Article Title: Thrombus-targeting nanosystems: Differential performance in arterial and venous circulation.
    Article Snippet: The hemodynamic differences between arterial and venous systems pose significant challenges for the nanomedicine-based thrombus targeting.. This study constructed three thrombus-targeting strategies: molecular recognition-based targeting, enzyme-driven chemotactic motion, and a combined targeting strategy that integrates both mechanisms.. Their thrombus-targeting capability and thrombolytic efficacy were systematically compared in arterial and venous thrombus models.



    Similar Products

    96
    ATCC sub confluent huvec
    Sub Confluent Huvec, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/confluent+huvec/HUV-EC-C/us11701366-312-0-7
    Average 96 stars, based on 1 article reviews
    sub confluent huvec - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    98
    PromoCell confluent huvec cells
    Confluent Huvec Cells, supplied by PromoCell, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/confluent+huvec/HUVEC-c+Human+Umbilical+Vein+Endothelial+Cells/pm39984928-99-0-13
    Average 98 stars, based on 1 article reviews
    confluent huvec cells - by Bioz Stars, 2026-09
    98/100 stars
      Buy from Supplier

    98
    PromoCell venous endothelial cells ecs confluent culture human umbilical vein ecs
    Venous Endothelial Cells Ecs Confluent Culture Human Umbilical Vein Ecs, supplied by PromoCell, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/confluent+huvec/HUVEC-c+Human+Umbilical+Vein+Endothelial+Cells/10__1016_slash_j__bvth__2025__100103-68-0-13
    Average 98 stars, based on 1 article reviews
    venous endothelial cells ecs confluent culture human umbilical vein ecs - by Bioz Stars, 2026-09
    98/100 stars
      Buy from Supplier

    99
    Thermo Fisher confluent huvecs
    Confluent Huvecs, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/confluent+huvec/Trypsin/pm38185718-187-3-11
    Average 99 stars, based on 1 article reviews
    confluent huvecs - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    90
    Wolters Kluwer Health confluent human umbilical vein endothelial cell (huvec) monolayers
    Confluent Human Umbilical Vein Endothelial Cell (Huvec) Monolayers, supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/confluent+huvec/huvecs/10__1097_slash_ta__0000000000004142-45-6-15
    Average 90 stars, based on 1 article reviews
    confluent human umbilical vein endothelial cell (huvec) monolayers - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    98
    PromoCell confluent human umbilical vein endothelial cells
    (A) Fluorescently-labeled SVEC4-10 LSS-lEVs (red) were injected into the mouse bloodstream. Animals were sacrificed after 30 min and aortas were harvested. <t>Endothelial</t> cells (green; Cadherin-5 staining) were imaged by confocal microscopy. (B) Fluorescently-labeled HUVEC LSS-lEVs (red) were incubated for 90 min with HUVECs exposed to HSS or LSS conditions for 24 h. Cells were fixed, stained for Cadherin-5 (green) and imaged by confocal microscopy. (C) Fluorescently-labeled HUVEC-derived LSS-lEVs were incubated for varying periods min with HUVECs exposed to HSS (blue) or LSS (red) conditions for 24 h. Representative quantifications of EV signal per cell from confocal images captured at different time points (15 fields per condition, *P<0.05, ****P<0.0001, One-way Anova). (D) Fluorescently-labeled HUVEC-derived HSS-lEVs (blue) or LSS-lEVs (red) were incubated for 90 min with HUVECs exposed to HSS or LSS conditions for 24 h. Representative quantifications of EV signal per cell from confocal images (15-17 fields per condition, ***P<0.001, ****P<0.0001, One-way Anova). (E) Fluorescently-labeled HUVEC-derived HSS-(blue) or LSS-(red) lEVs (left) or sEVs (right) were incubated for 90 min with HUVECs exposed to HSS or LSS conditions for 24 h. % of cells positive for EV signal was analyzed by flow cytometry. Data represent means ± SEM of 7 independent experiments, *P<0.05, **P<0.01, ***P<0.001, One-way Anova. (F) Fluorescently-labeled HUVEC-derived LSS lEVs or sEVs were incubated with HUVECs exposed to LSS conditions for 24 h. Cells were and visualized by image flow cytometry. (G) Fluorescently-labeled HUVEC-derived LSS lEVs (left) or sEVs (right) were incubated for 90 min, in the presence of endocytosis inhibitors, with HUVECs exposed to LSS conditions for 24 h. % of cells positive for EV signal, relative to Cont, was analyzed by flow cytometry. Data represent means ± SEM, relative to Cont, of 6 independent experiments, *P<0.05, **P<0.01, *** P<0.001, Friedman test. (H) Fluorescently-labeled lEVs derived from HUVECs exposed to LSS (Endo-LSS) or HSS (Endo-LSS), peripheral blood mononuclear cells (PMBC), neutrophils, platelets, red blood cells (RBC) or platelet free plasma (PFP) were incubated for 90 min with HUVECs exposed to LSS conditions for 24 h. % of cells positive for EV signal was analyzed by flow cytometry. Data represent means ± SEM of 4 independent experiments, ***P<0.001, ****P<0.0001, One-way Anova.
    Confluent Human Umbilical Vein Endothelial Cells, supplied by PromoCell, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/confluent+huvec/Human+Umbilical+Vein+Endothelial+Cells+(HUVEC)+single+donor/bio_rxiv__2022__12__31__522373-139-0-13
    Average 98 stars, based on 1 article reviews
    confluent human umbilical vein endothelial cells - by Bioz Stars, 2026-09
    98/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology confluent huvec
    (A) Fluorescently-labeled SVEC4-10 LSS-lEVs (red) were injected into the mouse bloodstream. Animals were sacrificed after 30 min and aortas were harvested. <t>Endothelial</t> cells (green; Cadherin-5 staining) were imaged by confocal microscopy. (B) Fluorescently-labeled HUVEC LSS-lEVs (red) were incubated for 90 min with HUVECs exposed to HSS or LSS conditions for 24 h. Cells were fixed, stained for Cadherin-5 (green) and imaged by confocal microscopy. (C) Fluorescently-labeled HUVEC-derived LSS-lEVs were incubated for varying periods min with HUVECs exposed to HSS (blue) or LSS (red) conditions for 24 h. Representative quantifications of EV signal per cell from confocal images captured at different time points (15 fields per condition, *P<0.05, ****P<0.0001, One-way Anova). (D) Fluorescently-labeled HUVEC-derived HSS-lEVs (blue) or LSS-lEVs (red) were incubated for 90 min with HUVECs exposed to HSS or LSS conditions for 24 h. Representative quantifications of EV signal per cell from confocal images (15-17 fields per condition, ***P<0.001, ****P<0.0001, One-way Anova). (E) Fluorescently-labeled HUVEC-derived HSS-(blue) or LSS-(red) lEVs (left) or sEVs (right) were incubated for 90 min with HUVECs exposed to HSS or LSS conditions for 24 h. % of cells positive for EV signal was analyzed by flow cytometry. Data represent means ± SEM of 7 independent experiments, *P<0.05, **P<0.01, ***P<0.001, One-way Anova. (F) Fluorescently-labeled HUVEC-derived LSS lEVs or sEVs were incubated with HUVECs exposed to LSS conditions for 24 h. Cells were and visualized by image flow cytometry. (G) Fluorescently-labeled HUVEC-derived LSS lEVs (left) or sEVs (right) were incubated for 90 min, in the presence of endocytosis inhibitors, with HUVECs exposed to LSS conditions for 24 h. % of cells positive for EV signal, relative to Cont, was analyzed by flow cytometry. Data represent means ± SEM, relative to Cont, of 6 independent experiments, *P<0.05, **P<0.01, *** P<0.001, Friedman test. (H) Fluorescently-labeled lEVs derived from HUVECs exposed to LSS (Endo-LSS) or HSS (Endo-LSS), peripheral blood mononuclear cells (PMBC), neutrophils, platelets, red blood cells (RBC) or platelet free plasma (PFP) were incubated for 90 min with HUVECs exposed to LSS conditions for 24 h. % of cells positive for EV signal was analyzed by flow cytometry. Data represent means ± SEM of 4 independent experiments, ***P<0.001, ****P<0.0001, One-way Anova.
    Confluent Huvec, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/confluent+huvec/siRNA+Transfection+Reagent/pm36428974-43-24-30
    Average 96 stars, based on 1 article reviews
    confluent huvec - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    90
    Lonza confluent endothelial cells huvec
    (A) Fluorescently-labeled SVEC4-10 LSS-lEVs (red) were injected into the mouse bloodstream. Animals were sacrificed after 30 min and aortas were harvested. <t>Endothelial</t> cells (green; Cadherin-5 staining) were imaged by confocal microscopy. (B) Fluorescently-labeled HUVEC LSS-lEVs (red) were incubated for 90 min with HUVECs exposed to HSS or LSS conditions for 24 h. Cells were fixed, stained for Cadherin-5 (green) and imaged by confocal microscopy. (C) Fluorescently-labeled HUVEC-derived LSS-lEVs were incubated for varying periods min with HUVECs exposed to HSS (blue) or LSS (red) conditions for 24 h. Representative quantifications of EV signal per cell from confocal images captured at different time points (15 fields per condition, *P<0.05, ****P<0.0001, One-way Anova). (D) Fluorescently-labeled HUVEC-derived HSS-lEVs (blue) or LSS-lEVs (red) were incubated for 90 min with HUVECs exposed to HSS or LSS conditions for 24 h. Representative quantifications of EV signal per cell from confocal images (15-17 fields per condition, ***P<0.001, ****P<0.0001, One-way Anova). (E) Fluorescently-labeled HUVEC-derived HSS-(blue) or LSS-(red) lEVs (left) or sEVs (right) were incubated for 90 min with HUVECs exposed to HSS or LSS conditions for 24 h. % of cells positive for EV signal was analyzed by flow cytometry. Data represent means ± SEM of 7 independent experiments, *P<0.05, **P<0.01, ***P<0.001, One-way Anova. (F) Fluorescently-labeled HUVEC-derived LSS lEVs or sEVs were incubated with HUVECs exposed to LSS conditions for 24 h. Cells were and visualized by image flow cytometry. (G) Fluorescently-labeled HUVEC-derived LSS lEVs (left) or sEVs (right) were incubated for 90 min, in the presence of endocytosis inhibitors, with HUVECs exposed to LSS conditions for 24 h. % of cells positive for EV signal, relative to Cont, was analyzed by flow cytometry. Data represent means ± SEM, relative to Cont, of 6 independent experiments, *P<0.05, **P<0.01, *** P<0.001, Friedman test. (H) Fluorescently-labeled lEVs derived from HUVECs exposed to LSS (Endo-LSS) or HSS (Endo-LSS), peripheral blood mononuclear cells (PMBC), neutrophils, platelets, red blood cells (RBC) or platelet free plasma (PFP) were incubated for 90 min with HUVECs exposed to LSS conditions for 24 h. % of cells positive for EV signal was analyzed by flow cytometry. Data represent means ± SEM of 4 independent experiments, ***P<0.001, ****P<0.0001, One-way Anova.
    Confluent Endothelial Cells Huvec, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/confluent+huvec/human+umbilical+vein+endothelial+cells++huvecs+/pm34799423-118-0-4
    Average 90 stars, based on 1 article reviews
    confluent endothelial cells huvec - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    (A) Fluorescently-labeled SVEC4-10 LSS-lEVs (red) were injected into the mouse bloodstream. Animals were sacrificed after 30 min and aortas were harvested. Endothelial cells (green; Cadherin-5 staining) were imaged by confocal microscopy. (B) Fluorescently-labeled HUVEC LSS-lEVs (red) were incubated for 90 min with HUVECs exposed to HSS or LSS conditions for 24 h. Cells were fixed, stained for Cadherin-5 (green) and imaged by confocal microscopy. (C) Fluorescently-labeled HUVEC-derived LSS-lEVs were incubated for varying periods min with HUVECs exposed to HSS (blue) or LSS (red) conditions for 24 h. Representative quantifications of EV signal per cell from confocal images captured at different time points (15 fields per condition, *P<0.05, ****P<0.0001, One-way Anova). (D) Fluorescently-labeled HUVEC-derived HSS-lEVs (blue) or LSS-lEVs (red) were incubated for 90 min with HUVECs exposed to HSS or LSS conditions for 24 h. Representative quantifications of EV signal per cell from confocal images (15-17 fields per condition, ***P<0.001, ****P<0.0001, One-way Anova). (E) Fluorescently-labeled HUVEC-derived HSS-(blue) or LSS-(red) lEVs (left) or sEVs (right) were incubated for 90 min with HUVECs exposed to HSS or LSS conditions for 24 h. % of cells positive for EV signal was analyzed by flow cytometry. Data represent means ± SEM of 7 independent experiments, *P<0.05, **P<0.01, ***P<0.001, One-way Anova. (F) Fluorescently-labeled HUVEC-derived LSS lEVs or sEVs were incubated with HUVECs exposed to LSS conditions for 24 h. Cells were and visualized by image flow cytometry. (G) Fluorescently-labeled HUVEC-derived LSS lEVs (left) or sEVs (right) were incubated for 90 min, in the presence of endocytosis inhibitors, with HUVECs exposed to LSS conditions for 24 h. % of cells positive for EV signal, relative to Cont, was analyzed by flow cytometry. Data represent means ± SEM, relative to Cont, of 6 independent experiments, *P<0.05, **P<0.01, *** P<0.001, Friedman test. (H) Fluorescently-labeled lEVs derived from HUVECs exposed to LSS (Endo-LSS) or HSS (Endo-LSS), peripheral blood mononuclear cells (PMBC), neutrophils, platelets, red blood cells (RBC) or platelet free plasma (PFP) were incubated for 90 min with HUVECs exposed to LSS conditions for 24 h. % of cells positive for EV signal was analyzed by flow cytometry. Data represent means ± SEM of 4 independent experiments, ***P<0.001, ****P<0.0001, One-way Anova.

    Journal: bioRxiv

    Article Title: Atheroprone shear stress stimulates noxious endothelial extracellular vesicle uptake by MCAM and PECAM-1 cell adhesion molecules

    doi: 10.1101/2022.12.31.522373

    Figure Lengend Snippet: (A) Fluorescently-labeled SVEC4-10 LSS-lEVs (red) were injected into the mouse bloodstream. Animals were sacrificed after 30 min and aortas were harvested. Endothelial cells (green; Cadherin-5 staining) were imaged by confocal microscopy. (B) Fluorescently-labeled HUVEC LSS-lEVs (red) were incubated for 90 min with HUVECs exposed to HSS or LSS conditions for 24 h. Cells were fixed, stained for Cadherin-5 (green) and imaged by confocal microscopy. (C) Fluorescently-labeled HUVEC-derived LSS-lEVs were incubated for varying periods min with HUVECs exposed to HSS (blue) or LSS (red) conditions for 24 h. Representative quantifications of EV signal per cell from confocal images captured at different time points (15 fields per condition, *P<0.05, ****P<0.0001, One-way Anova). (D) Fluorescently-labeled HUVEC-derived HSS-lEVs (blue) or LSS-lEVs (red) were incubated for 90 min with HUVECs exposed to HSS or LSS conditions for 24 h. Representative quantifications of EV signal per cell from confocal images (15-17 fields per condition, ***P<0.001, ****P<0.0001, One-way Anova). (E) Fluorescently-labeled HUVEC-derived HSS-(blue) or LSS-(red) lEVs (left) or sEVs (right) were incubated for 90 min with HUVECs exposed to HSS or LSS conditions for 24 h. % of cells positive for EV signal was analyzed by flow cytometry. Data represent means ± SEM of 7 independent experiments, *P<0.05, **P<0.01, ***P<0.001, One-way Anova. (F) Fluorescently-labeled HUVEC-derived LSS lEVs or sEVs were incubated with HUVECs exposed to LSS conditions for 24 h. Cells were and visualized by image flow cytometry. (G) Fluorescently-labeled HUVEC-derived LSS lEVs (left) or sEVs (right) were incubated for 90 min, in the presence of endocytosis inhibitors, with HUVECs exposed to LSS conditions for 24 h. % of cells positive for EV signal, relative to Cont, was analyzed by flow cytometry. Data represent means ± SEM, relative to Cont, of 6 independent experiments, *P<0.05, **P<0.01, *** P<0.001, Friedman test. (H) Fluorescently-labeled lEVs derived from HUVECs exposed to LSS (Endo-LSS) or HSS (Endo-LSS), peripheral blood mononuclear cells (PMBC), neutrophils, platelets, red blood cells (RBC) or platelet free plasma (PFP) were incubated for 90 min with HUVECs exposed to LSS conditions for 24 h. % of cells positive for EV signal was analyzed by flow cytometry. Data represent means ± SEM of 4 independent experiments, ***P<0.001, ****P<0.0001, One-way Anova.

    Article Snippet: Confluent Human Umbilical Vein Endothelial Cells (HUVEC; passage 2-4; 20 different primary cultures; PromoCell) were cultured on 0,2 % gelatin-coated slides, in Endothelial Cell Basal Medium (ECBM, PromoCell), supplemented with 2 % Fetal Calf Serum (PromoCell), growth factors (0.4% ECGS, 0.1 ng/mL EGF, 1 ng/mL ß-FGF), heparin (90 μg/mL), hydrocortisone (1 μg/mL), Amphotericin B (10 μg/L, Gibco), Streptomycin (100 IU/mL, Gibco) and Penicillin (100 IU/mL, Gibco).

    Techniques: Labeling, Injection, Staining, Confocal Microscopy, Incubation, Derivative Assay, Flow Cytometry, Clinical Proteomics